NCT00263575 2024-06-18Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer PatientsKyowa Kirin Co., Ltd.Phase 3 Completed139 enrolled 7 charts
NCT00842829 2012-10-01Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant PatientsTeva Branded Pharmaceutical Products R&D, Inc.Phase 4 Terminated330 enrolled 32 charts